Please provide your email address to receive an email when new articles are posted on . Patients with pediatric discoid lupus erythematosus combined with systemic lupus erythematosus were most likely ...

The U.S. Food & Drug Administration (FDA) has granted approval for a novel and less invasive belimumab (Benlysta®) treatment for children with systemic lupus erythematosus (SLE) ages five years and ...

The 200-mg subcutaneous injection is for children 5 years and older. HealthDay News — The US Food and Drug Administration has approved a 200 mg subcutaneous route of administration of Benlysta ...

Several years of preliminary research results suggest chimeric antigen receptor (CAR) T-cell therapy could benefit pediatric patients with refractory systemic lupus erythematosus (SLE). When diagnosed ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Growth impairment was reported in 23.6% ...

In this retrospective analysis, responses persisted with hydroxychloroquine treatment. Results of a study suggest treatment using hydroxychloroquine (HCQ) for immune thrombocytopenia (ITP) related to ...

The findings mean it may be feasible to use adult systemic lupus nephritis (SLE) trial data to reduce the data needed for pediatric indications. Efficacy data from trials of adults with systemic lupus ...

Seattle Children’s is the first FDA-authorized site to deliver an experimental CAR T-cell therapy to children with lupus, the system said March 11. About 20% of lupus patients have disease onset ...

The findings demonstrated that RAIL, a biomarker-based urine test, can effectively distinguish between active lupus kidney ...

When people talk about “lupus,” they usually mean systemic lupus erythematosus (SLE), the most common type. But there are several other types and subtypes, some of which can overlap. Lupus is a ...